247 related articles for article (PubMed ID: 26072975)
41. Association of the MTHFR C677T polymorphism with primary brain tumor risk.
Xu C; Yuan L; Tian H; Cao H; Chen S
Tumour Biol; 2013 Dec; 34(6):3457-64. PubMed ID: 23846816
[TBL] [Abstract][Full Text] [Related]
42. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer.
Zhong S; Chen Z; Yu X; Li W; Tang J; Zhao J
Mol Biol Rep; 2014 Sep; 41(9):5775-85. PubMed ID: 24973876
[TBL] [Abstract][Full Text] [Related]
43. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.
Sheng X; Zhang Y; Zhao E; Lu S; Zheng X; Ge H; Lu W
Mol Biol Rep; 2012 Oct; 39(10):9669-79. PubMed ID: 22729883
[TBL] [Abstract][Full Text] [Related]
44. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis.
Hou X; Chen X; Shi J
Gene; 2015 Jul; 565(1):39-44. PubMed ID: 25839940
[TBL] [Abstract][Full Text] [Related]
45. Folate pathway gene MTHFR C677T polymorphism and risk of lung cancer in Asian populations.
Rai V
Asian Pac J Cancer Prev; 2014; 15(21):9259-64. PubMed ID: 25422209
[TBL] [Abstract][Full Text] [Related]
46. Association of MTHFR C677T polymorphism and risk of cerebrovascular disease in Chinese population: an updated meta-analysis.
Zhang MJ; Li JC; Yin YW; Li BH; Liu Y; Liao SQ; Gao CY; Zhang LL
J Neurol; 2014 May; 261(5):925-35. PubMed ID: 24603976
[TBL] [Abstract][Full Text] [Related]
47. Significant association between MTHFR C677T polymorphism and thyroid cancer risk: evidence from a meta-analysis.
Chen Y; Wang B; Yan S; Wang YG
Genet Test Mol Biomarkers; 2014 Oct; 18(10):695-702. PubMed ID: 25007377
[TBL] [Abstract][Full Text] [Related]
48. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
Xu R; Wu H; Zhang S; Zhou H; Liang L
Neurosci Lett; 2018 Sep; 683():69-74. PubMed ID: 29953924
[TBL] [Abstract][Full Text] [Related]
49. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
50. MTHFR C677T polymorphism and migraine risk: a meta-analysis.
Liu R; Geng P; Ma M; Yu S; Yang M; He M; Dong Z; Zhang W
J Neurol Sci; 2014 Jan; 336(1-2):68-73. PubMed ID: 24183284
[TBL] [Abstract][Full Text] [Related]
51. Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.
Guan H; Xia MD; Wang M; Guan YJ; Lyu XC
Medicine (Baltimore); 2020 Aug; 99(35):e21558. PubMed ID: 32871871
[TBL] [Abstract][Full Text] [Related]
52. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies.
Yan L; Zhao L; Long Y; Zou P; Ji G; Gu A; Zhao P
PLoS One; 2012; 7(10):e41689. PubMed ID: 23056169
[TBL] [Abstract][Full Text] [Related]
53. Association between MTHFR C677T polymorphism and risk of coronary artery disease in the Chinese population: meta-analysis.
Li L; Yu H; Zhang H; Wang J; Hu W
Herz; 2022 Dec; 47(6):553-563. PubMed ID: 35089369
[TBL] [Abstract][Full Text] [Related]
54. MTHFR C677T polymorphism contributes to the risk for gastric cancer.
Yan S; Xu D; Wang P; Wang P; Liu C; Hua C; Jiang T; Zhang B; Li Z; Lu L; Liu X; Wang B; Zhang D; Zhang R; He S; Sun B; Wang X
Tumour Biol; 2014 Mar; 35(3):2123-32. PubMed ID: 24122207
[TBL] [Abstract][Full Text] [Related]
55. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
Ren A; Wang J
Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
[TBL] [Abstract][Full Text] [Related]
56. Methylenetrahydrofolate Reductase Gene C677T Polymorphism and Diabetic Retinopathy: a Meta-Analysis.
Shen C; Zhao M; Li YY; Liu NP
Chin Med Sci J; 2020 Mar; 35(1):71-84. PubMed ID: 32299540
[TBL] [Abstract][Full Text] [Related]
57. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
Guo S; Jiang X; Chen X; Chen L; Li X; Jia Y
Gene; 2015 Jul; 565(1):90-5. PubMed ID: 25841988
[TBL] [Abstract][Full Text] [Related]
58. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
59. Methylenetetrahydrofolate reductase C677T gene polymorphism and coronary artery disease in a Chinese Han population: a meta-analysis.
Li YY
Metabolism; 2012 Jun; 61(6):846-52. PubMed ID: 22146089
[TBL] [Abstract][Full Text] [Related]
60. The MTHFR C677T Polymorphism and Risk of Intracerebral Hemorrhage in a Chinese Han Population.
Hu X; Tao C; Xie Z; Li Y; Zheng J; Fang Y; Lin S; Li H; You C
Med Sci Monit; 2016 Jan; 22():127-33. PubMed ID: 26757363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
